BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16314184)

  • 21. The expression of syndecan-1 in psoriatic epidermis.
    Tomas D; Vucić M; Situm M; Kruslin B
    Arch Dermatol Res; 2008 Aug; 300(7):393-5. PubMed ID: 18386024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant caveolin-1 expression in psoriasis: a signalling hypothesis.
    Campbell L; Gumbleton M
    IUBMB Life; 2000 Dec; 50(6):361-4. PubMed ID: 11327308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of cell death and proliferation in psoriatic epidermis.
    Kawashima K; Doi H; Ito Y; Shibata MA; Yoshinaka R; Otsuki Y
    J Dermatol Sci; 2004 Sep; 35(3):207-14. PubMed ID: 15381242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ.
    Kane CJ; Knapp AM; Mansbridge JN; Hanawalt PC
    J Cell Physiol; 1990 Jul; 144(1):144-50. PubMed ID: 1694857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etanercept does not have an apoptosis-inducing effect on psoriatic keratinocytes.
    Tatlican S; Arikok A; Gulbahar O; Eren C; Cevirgen B; Eskioglu F
    J Dermatolog Treat; 2010 Sep; 21(5):306-10. PubMed ID: 19878038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease.
    Ciccocioppo R; Finamore A; Ara C; Di Sabatino A; Mengheri E; Corazza GR
    Am J Clin Pathol; 2006 Apr; 125(4):502-11. PubMed ID: 16627260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in the desquamation-related proteolytic cleavage of corneodesmosin and other corneodesmosomal proteins in psoriatic lesional epidermis.
    Simon M; Tazi-Ahnini R; Jonca N; Caubet C; Cork MJ; Serre G
    Br J Dermatol; 2008 Jul; 159(1):77-85. PubMed ID: 18460028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis in psoriatic epidermis.
    Heenen M; Simonart T
    J Cutan Pathol; 2008 Mar; 35(3):346. PubMed ID: 18251754
    [No Abstract]   [Full Text] [Related]  

  • 29. Altered expression of occludin and tight junction formation in psoriasis.
    Yoshida Y; Morita K; Mizoguchi A; Ide C; Miyachi Y
    Arch Dermatol Res; 2001 May; 293(5):239-44. PubMed ID: 11409568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal fatty-acid-binding protein in psoriasis, basal and squamous cell carcinomas: an immunohistological study.
    Masouyé I; Saurat JH; Siegenthaler G
    Dermatology; 1996; 192(3):208-13. PubMed ID: 8726632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis.
    Chang EY; Hammerberg C; Fisher G; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
    Arch Dermatol; 1992 Nov; 128(11):1479-85. PubMed ID: 1359841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
    J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional tight junction barrier localizes in the second layer of the stratum granulosum of human epidermis.
    Yoshida K; Yokouchi M; Nagao K; Ishii K; Amagai M; Kubo A
    J Dermatol Sci; 2013 Aug; 71(2):89-99. PubMed ID: 23712060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.
    van Erp PE; Rijzewijk JJ; Boezeman JB; Leenders J; de Mare S; Schalkwijk J; van de Kerkhof PC; Ramaekers FC; Bauer FW
    Am J Pathol; 1989 Nov; 135(5):865-70. PubMed ID: 2479273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis.
    Tervaniemi MH; Katayama S; Skoog T; Siitonen HA; Vuola J; Nuutila K; Sormunen R; Johnsson A; Linnarsson S; Suomela S; Kankuri E; Kere J; Elomaa O
    Sci Rep; 2016 Mar; 6():22745. PubMed ID: 26976200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of interleukin-4 receptors on psoriatic epidermal cells.
    Prens E; Hegmans J; Lien RC; Debets R; Troost R; van Joost T; Benner R
    Am J Pathol; 1996 May; 148(5):1493-502. PubMed ID: 8623919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lectin binding of psoriatic skin].
    Wollina U; Hipler C; Henkel U; Schaarschmidt H; Knopf B
    Z Hautkr; 1986 Sep; 61(17):1241-9. PubMed ID: 3776279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nestin expression is increased in the suprabasal epidermal layer in psoriasis vulgaris.
    Watarai A; Amoh Y; Maejima H; Hamada Y; Katsuoka K
    Acta Derm Venereol; 2013 Jan; 93(1):39-43. PubMed ID: 22854836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The different structures containing tight junction proteins in epidermal and other stratified epithelial cells, including squamous cell metaplasia.
    Schlüter H; Moll I; Wolburg H; Franke WW
    Eur J Cell Biol; 2007 Dec; 86(11-12):645-55. PubMed ID: 17291627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an in vitro psoriatic skin model by tissue engineering.
    Jean J; Lapointe M; Soucy J; Pouliot R
    J Dermatol Sci; 2009 Jan; 53(1):19-25. PubMed ID: 18783923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.